Sarepta Therapeutics (NASDAQ: SRPT) files Form 13F with 1 entry

Rhea-AI Filing Summary

Sarepta Therapeutics, Inc. filed a Form 13F as an institutional investment manager. The filing lists 1 Form 13F information table entry and reports a total table value of $0. The report is signed by Ryan Wong, Executive Vice President and Chief Financial Officer, dated 02-12-2026.

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL

OMB Number:			3235-0006
Estimated average burden
hours per response:			23.8

Report for the Calendar Year or Quarter Ended: 12-31-2025

Check here if Amendment		Amendment Number:
This Amendment (Check only one.):		is a restatement.
		adds new holdings entries.

Institutional Investment Manager Filing this Report:
Name:	Sarepta Therapeutics, Inc.
Address:	215 First Street
	Suite 415
	Cambridge, MA 02142
Form 13F File Number:	028-26297
CRD Number (if applicable):
SEC File Number (if applicable):	001-14895

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name:		Ryan Wong
Title:		Executive Vice President, Chief Financial Officer
Phone:		617-274-4000
Signature, Place, and Date of Signing:
/s/ Ryan Wong			Las Vegas, NV	02-12-2026
[Signature]			[City, State]	[Date]

Report Type (Check only one.):
X	13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
	13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
	13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

Form 13F Summary Page
	Report Summary:
	Number of Other Included Managers:		0
	Form 13F Information Table Entry Total:		1
	Form 13F Information Table Value Total:		0
			(round to nearest dollar)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.

[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]

NONE

FAQ

What did Sarepta Therapeutics report on its Form 13F (SRPT)?

It reported one Form 13F information table entry with aggregate value $0. The filing shows the manager listed 1 entry and a Form 13F information table value total of $0, per the summary page.

Who signed the Form 13F for Sarepta Therapeutics?

The report is signed by Ryan Wong, EVP and Chief Financial Officer. The signature block identifies Ryan Wong and records the signing location as Las Vegas, NV with date 02-12-2026.

How many other included managers are listed in the Sarepta 13F filing?

The filing indicates zero other included managers. The Form 13F summary page shows "Number of Other Included Managers: 0" and a separate list section stating "NONE."

Does the filing say the SEC reviewed the information?

No—the cover statement disclaims SEC review or determination of accuracy. The filing begins with the standard notice that the SEC has not necessarily reviewed the information and readers should not assume accuracy or completeness.

What is the filer’s address shown on the Form 13F?

The filing lists the address as 215 First Street, Suite 415, Cambridge, MA 02142. That address appears on the cover information for the institutional investment manager submitting the report.